157 related articles for article (PubMed ID: 3411179)
1. Luteal-phase support in stimulated cycles in an in vitro fertilization/embryo transfer program: progesterone versus human chorionic gonadotropin.
Nader S; Berkowitz AS; Ochs D; Held B; Winkel CA
J In Vitro Fert Embryo Transf; 1988 Apr; 5(2):81-4. PubMed ID: 3411179
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of human chorionic gonadotropin support following in vitro fertilization and embryo transfer.
Buvat J; Marcolin G; Herbaut JC; Dehaene JL; Verbecq P; Fourlinnie JC
Fertil Steril; 1988 Mar; 49(3):458-61. PubMed ID: 3277865
[TBL] [Abstract][Full Text] [Related]
3. Luteal rescue in in vitro fertilization-embryo transfer.
Hutchinson-Williams KA; DeCherney AH; Lavy G; Diamond MP; Naftolin F; Lunenfeld B
Fertil Steril; 1990 Mar; 53(3):495-501. PubMed ID: 2307247
[TBL] [Abstract][Full Text] [Related]
4. Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support.
Balasch J; Creus M; Fábregues F; Carmona F; Casamitjana R; Peñarrubia J; Rivera F; Vanrell JA
Gynecol Endocrinol; 1995 Mar; 9(1):51-8. PubMed ID: 7793300
[TBL] [Abstract][Full Text] [Related]
5. Salivary oestradiol and progesterone after in vitro fertilization and embryo transfer using different luteal support regimens.
Wong YF; Loong EP; Mao KR; Tam PP; Panesar NS; Neale E; Chang AM
Reprod Fertil Dev; 1990; 2(4):351-8. PubMed ID: 2217893
[TBL] [Abstract][Full Text] [Related]
6. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins.
Herman A; Ron-El R; Golan A; Raziel A; Soffer Y; Caspi E
Fertil Steril; 1990 Jan; 53(1):92-6. PubMed ID: 2104811
[TBL] [Abstract][Full Text] [Related]
8. Luteal function following ovarian stimulation in rhesus monkeys for in vitro fertilization: atypical response to human chorionic gonadotropin treatment simulating early pregnancy.
VandeVoort CA; Hess DL; Stouffer RL
Fertil Steril; 1988 Jun; 49(6):1071-5. PubMed ID: 3131158
[TBL] [Abstract][Full Text] [Related]
9. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
Claman P; Domingo M; Leader A
Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.
Araujo E; Bernardini L; Frederick JL; Asch RH; Balmaceda JP
J Assist Reprod Genet; 1994 Feb; 11(2):74-8. PubMed ID: 7819706
[TBL] [Abstract][Full Text] [Related]
11. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone.
Herman A; Raziel A; Strassburger D; Soffer Y; Bukovsky I; Ron-El R
Hum Reprod; 1996 Jul; 11(7):1552-7. PubMed ID: 8671503
[TBL] [Abstract][Full Text] [Related]
12. Serum progesterone levels in women treated with human menopausal gonadotropin and human chorionic gonadotropin for in vitro fertilization.
Huang KE; Muechler EK; Schwarz KR; Goggin M; Graham MC
Fertil Steril; 1986 Nov; 46(5):903-6. PubMed ID: 3096786
[TBL] [Abstract][Full Text] [Related]
13. Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over oral progesterone.
Buvat J; Marcolin G; Guittard C; Herbaut JC; Louvet AL; Dehaene JL
Fertil Steril; 1990 Mar; 53(3):490-4. PubMed ID: 2407565
[TBL] [Abstract][Full Text] [Related]
14. Luteal phase support with hCG does not improve fecundity rate in human menopausal gonadotropin-stimulated cycles.
Keenan JA; Moghissi KS
Obstet Gynecol; 1992 Jun; 79(6):983-7. PubMed ID: 1579327
[TBL] [Abstract][Full Text] [Related]
15. [Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer].
Hara S
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2043-50. PubMed ID: 3123577
[TBL] [Abstract][Full Text] [Related]
16. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
[TBL] [Abstract][Full Text] [Related]
17. A comparative, randomized study of three different progesterone support of the luteal phase following IVF/ET program.
Artini PG; Volpe A; Angioni S; Galassi MC; Battaglia C; Genazzani AR
J Endocrinol Invest; 1995 Jan; 18(1):51-6. PubMed ID: 7759785
[TBL] [Abstract][Full Text] [Related]
18. Effects of low-dose human chorionic gonadotropin on corpus luteum function after embryo transfer.
Mahadevan MM; Leader A; Taylor PJ
J In Vitro Fert Embryo Transf; 1985 Dec; 2(4):190-4. PubMed ID: 4093702
[TBL] [Abstract][Full Text] [Related]
19. Active corpus luteum function at pre-, peri- and postimplantation is essential for a viable pregnancy.
Liu HC; Pyrgiotis E; Davis O; Rosenwaks Z
Early Pregnancy; 1995 Dec; 1(4):281-7. PubMed ID: 9363260
[TBL] [Abstract][Full Text] [Related]
20. Luteal phase hormonal profile in prediction of pregnancy outcome after assisted reproduction.
Vicdan K; Zeki Isik A
Eur J Obstet Gynecol Reprod Biol; 2001 May; 96(1):98-101. PubMed ID: 11311769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
